Opportunity Information: Apply for W81XWH 21 DMDRP TRA
The DoD Duchenne Muscular Dystrophy Research Program (DMDRP) Translational Research Award (FY21) is a Department of Defense funding opportunity designed to push promising Duchenne muscular dystrophy (DMD) research out of the purely basic science stage and closer to real-world clinical use. The central aim is to speed up translational research, meaning projects that deliberately connect laboratory discoveries with clinical observations and patient-focused realities, and then use that connection to move a potential therapy, tool, or intervention toward clinical application. In practice, the program is looking for work that sits in the space where basic mechanisms and clinical needs inform each other, rather than a simple one-direction path from bench to bedside.
A key feature of this award is the expectation that the research plan will show a two-way exchange between basic and clinical science. Ideas might begin with a lab finding, a trend uncovered in population data, or a clinician noticing something in patient care, but the application needs to demonstrate that clinical insights will continue to shape the scientific work and that scientific results will, in turn, refine clinical approaches. The opportunity is geared toward established projects that have already progressed beyond early-stage discovery and are positioned to have a near-term impact in clinical research or in the clinic itself. Because of that translational emphasis, applicants are required to include preliminary data that is directly relevant to DMD and supports the feasibility and rationale of the proposed project.
The scope of what can be supported includes pilot or proof-of-principle clinical trials, as well as correlative studies that help guide the development of drugs, devices, or other interventions. The announcement also signals a strong interest in therapies that can be effective across the lifespan, with a particular encouragement for projects that address adolescents and adults, groups that can be underrepresented in some DMD therapeutic development pipelines. Overall, the award is meant to back work with a clear line of sight to clinical utility, including studies that reduce uncertainty around how an intervention works, who it may help, and how it could be advanced toward broader clinical evaluation.
Administratively, this opportunity is listed as discretionary funding and may be made as either a grant or a cooperative agreement, depending on the specifics of the award. It falls under Science and Technology and other Research and Development activities and is associated with CFDA number 12.420. The administering agency is the Department of Defense, Department of the Army, via USAMRAA. Eligibility is listed as unrestricted, meaning it is broadly open to many types of applicant organizations, subject to any additional eligibility notes contained in the full solicitation. The funding opportunity number is W81XWH 21 DMDRP TRA, it was posted on May 27, 2021, and had an original closing date of December 1, 2021. The listing indicates an expectation of approximately two awards, and the award ceiling is shown as 0 in the source record, which typically means applicants need to rely on the official solicitation documents for the actual maximum funding level or budget constraints.Apply for W81XWH 21 DMDRP TRA
- The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Duchenne Muscular Dystrophy, Translational Research Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
- This funding opportunity was created on May 27, 2021.
- Applicants must submit their applications by Dec 01, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
DMDRP Translational Research Award (FY21) - Frequently Asked Questions
What is the DMDRP Translational Research Award (FY21)?
The DoD Duchenne Muscular Dystrophy Research Program (DMDRP) Translational Research Award (FY21) is a Department of Defense funding opportunity intended to move promising Duchenne muscular dystrophy (DMD) research beyond basic science and closer to real-world clinical use. It focuses on translational research projects that actively connect laboratory discoveries with clinical observations and patient-focused realities to advance a therapy, tool, or intervention toward clinical application.
What is the main goal of this award?
The central goal is to speed up translational research for DMD by supporting projects that have a clear line of sight to clinical utility. The program emphasizes work where basic mechanisms and clinical needs continuously inform each other, rather than a one-way progression from bench to bedside.
What does "translational research" mean in the context of this opportunity?
Translational research here refers to studies designed to bridge lab science and clinical practice in a deliberate, ongoing way. The award is looking for projects that use clinical observations to shape the scientific work and, in turn, use scientific results to refine clinical approaches and advance a potential therapy, tool, or intervention toward clinical use.
Does the program require both basic and clinical components?
The program expects the research plan to show a two-way exchange between basic and clinical science. Projects can start from different origins (a lab finding, population data trends, or clinician observations), but the application is expected to demonstrate continued interaction between clinical insights and scientific experimentation or analysis.
What types of projects are a good fit for this award?
The opportunity is geared toward established projects that have progressed beyond early-stage discovery and are positioned to have near-term impact in clinical research or clinical care. It supports work that reduces uncertainty around how an intervention works, who it may help, and how it can be advanced toward broader clinical evaluation.
Are early-stage, purely basic science projects appropriate for this award?
Based on the description, the award is not aimed at purely basic research that remains in early discovery. It is intended for projects that are already beyond the basic stage and can credibly move a DMD-related therapy, tool, or intervention closer to clinical application.
Is preliminary data required?
Yes. Applicants are required to include preliminary data that is directly relevant to Duchenne muscular dystrophy (DMD) and that supports both the feasibility and the rationale for the proposed project.
What kind of clinical research can be supported?
The scope includes pilot or proof-of-principle clinical trials as well as correlative studies that guide the development of drugs, devices, or other interventions. The emphasis is on studies that help move an intervention toward clinical application and broader clinical evaluation.
What are "correlative studies" in this announcement?
Correlative studies, as described in the opportunity, are studies that help guide development decisions for drugs, devices, or other interventions. They can help clarify how an intervention is working, identify who may benefit, and reduce uncertainty that could otherwise slow progression toward clinical evaluation.
Is the program interested in particular patient age groups?
Yes. The announcement signals strong interest in therapies that can be effective across the lifespan, and it particularly encourages projects that address adolescents and adults, who may be underrepresented in some DMD therapeutic development pipelines.
What is meant by a "two-way exchange" between clinical and basic science?
It means clinical observations and patient-focused realities should actively shape the scientific work, and scientific findings should loop back to refine clinical approaches. The project should not treat clinical work as a one-time validation step; instead, clinical and basic components should continuously inform each other throughout the project.
What kinds of starting points are acceptable for a project idea?
The opportunity notes that ideas might begin from a laboratory finding, a trend uncovered in population data, or a clinician noticing something in patient care. Regardless of where the idea begins, the proposal is expected to maintain the translational two-way exchange between clinical and basic science.
Which agency administers this funding opportunity?
The administering agency is the Department of Defense, Department of the Army, via USAMRAA.
What is the funding opportunity number?
The funding opportunity number is W81XWH 21 DMDRP TRA.
What is the CFDA number associated with this program?
The opportunity is associated with CFDA number 12.420.
What category of federal activity does this opportunity fall under?
It falls under Science and Technology and other Research and Development activities.
What type of funding mechanism is used (grant or cooperative agreement)?
The opportunity may be made as either a grant or a cooperative agreement, depending on the specifics of the award.
Is this discretionary funding?
Yes. The listing describes it as discretionary funding.
Who is eligible to apply?
Eligibility is listed as unrestricted, meaning it is broadly open to many types of applicant organizations, subject to any additional eligibility notes contained in the full solicitation.
How many awards were expected?
The listing indicates an expectation of approximately two awards.
What is the maximum award amount (award ceiling)?
The award ceiling is shown as 0 in the source record. This typically indicates that applicants should rely on the official solicitation documents for the actual maximum funding level and any budget constraints.
When was this opportunity posted?
It was posted on May 27, 2021.
What was the original closing date?
The original closing date was December 1, 2021.
What disease area is this opportunity focused on?
The award is specifically focused on Duchenne muscular dystrophy (DMD) and requires preliminary data directly relevant to DMD.
What is the program trying to accelerate for DMD?
The award is designed to accelerate the movement of promising DMD research toward clinical application by supporting translational projects with near-term clinical impact potential, including pilot/proof-of-principle trials and studies that guide intervention development.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: Building a comprehensive government approach to combating child labor and forced labor in Mexico
Previous opportunity: The Road to Global Entrepreneurship Week
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for W81XWH 21 DMDRP TRA
Applicants also applied for:
Applicants who have applied for this opportunity (W81XWH 21 DMDRP TRA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DoD Duchenne Muscular Dystrophy, Idea Development Award Apply for W81XWH 21 DMDRP IDA Funding Number: W81XWH 21 DMDRP IDA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Neurotoxin Exposure Treatment Parkinson’s, Investigator- Initiated Research Award Apply for W81XWH 21 NETP IIRA Funding Number: W81XWH 21 NETP IIRA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Neurotoxin Exposure Treatment Parkinson’s, Synergistic Idea Award Apply for W81XWH 21 NETP SIA Funding Number: W81XWH 21 NETP SIA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Neurotoxin Exposure Treatment Parkinson’s, Early Investigator Research Award Apply for W81XWH 21 NETP EIRA Funding Number: W81XWH 21 NETP EIRA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Predictive Intelligence for Pandemic Prevention Phase I: Development Grants Apply for 21 590 Funding Number: 21 590 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $1,000,000 |
| Computer and Information Science and Engineering (CISE) Research Initiation Initiative Apply for 21 591 Funding Number: 21 591 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $175,000 |
| NASA Innovative Advanced Concepts (NIAC) Phase I Apply for 80HQTR21NOA01 22NIAC A1 Funding Number: 80HQTR21NOA01 22NIAC A1 Agency: National Aeronautics and Space Administration, NASA Headquarters Category: Science and Technology and other Research and Development Funding Amount: $175,000 |
| Lualualei Protected Species Management Apply for W9126G 21 2 SOI 3684 Funding Number: W9126G 21 2 SOI 3684 Agency: Department of Defense, Fort Worth District Category: Science and Technology and other Research and Development Funding Amount: $2,672,228 |
| FY22 Bluefin Tuna Research Program Apply for NOAA NMFS SE 2022 2006951 Funding Number: NOAA NMFS SE 2022 2006951 Agency: Department of Commerce Category: Science and Technology and other Research and Development Funding Amount: $300,000 |
| Aquatic Fauna Florida Everglades Apply for W9126G 21 2 SOI 4382 Funding Number: W9126G 21 2 SOI 4382 Agency: Department of Defense, Fort Worth District Category: Science and Technology and other Research and Development Funding Amount: $488,537 |
| Alligator Ecological Florida Everglades Apply for W9126G 21 2 SOI 4384 Funding Number: W9126G 21 2 SOI 4384 Agency: Department of Defense, Fort Worth District Category: Science and Technology and other Research and Development Funding Amount: $145,053 |
| Promoting American Leadership, Values, and Economic Prosperity in Artificial Intelligence Apply for SFOP0008191 Funding Number: SFOP0008191 Agency: Department of State, Bureau of Economic and Business Affairs Category: Science and Technology and other Research and Development Funding Amount: $1,332,160 |
| Countering Weapons of Mass Destruction: Academic Research Initiative (ARI) Apply for DHS 21 CWMD 077 001 Funding Number: DHS 21 CWMD 077 001 Agency: Department of Homeland Security, Office of Procurement Operations - Grants Division Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Developing Natural and Nature-Based Features Based on Engineering With Nature® (EWN) and Landscape Architecture Principles for Project Locations Identified within, or in close proximity to, the Chesapeake Bay Watershed Apply for W81EWF 21 SOI 0020 Funding Number: W81EWF 21 SOI 0020 Agency: Department of Defense, Dept. of the Army -- Corps of Engineers Category: Science and Technology and other Research and Development Funding Amount: $180,000 |
| Developing an Engineering With Nature® (EWN) Approach for Resilience Through Military Installation and Community Engagement Apply for W81EWF 21 SOI 0019 Funding Number: W81EWF 21 SOI 0019 Agency: Department of Defense, Dept. of the Army -- Corps of Engineers Category: Science and Technology and other Research and Development Funding Amount: $1,500,000 |
| Integrated Training Area Management (ITAM) Support Fort Dix Apply for W9126G 21 2 SOI 3894 Funding Number: W9126G 21 2 SOI 3894 Agency: Department of Defense, Fort Worth District Category: Science and Technology and other Research and Development Funding Amount: $700,000 |
| Research Interests of the Air Force Office of Scientific Research Apply for FA9550 21 S 0001 Funding Number: FA9550 21 S 0001 Agency: Department of Defense, Air Force Office of Scientific Research Category: Science and Technology and other Research and Development Funding Amount: $100,000,000 |
| Nanoscale Interactions Apply for PD 21 1179 Funding Number: PD 21 1179 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Environmental Sustainability Apply for PD 21 7643 Funding Number: PD 21 7643 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Human-Guided Machine Learning Apply for W911NF 17 S 0003 SN MACHINE LEARNING Funding Number: W911NF 17 S 0003 SN MACHINE LEARNING Agency: Department of Defense, Dept of the Army -- Materiel Command Category: Science and Technology and other Research and Development Funding Amount: $2,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 21 DMDRP TRA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.